Education
About Us
Working with TipRanks
Follow Us
General Cannabis (DE:7A7)
:7A7
7A7 Stock Chart & Stats
Day’s Range― - ―
52-Week Range€0.10 - €0.10
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€2.53M
Enterprise ValueN/A
Total Cash (Recent Filing)€245.37K
Total Debt (Recent Filing)$17.42M
Price to Earnings (P/E)―
Beta4.90
Next Earnings
Aug 07, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding108,746,520
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.07
Price to Book (P/B)-1.21
Price to Sales (P/S)0.00
P/FCF Ratio-5.82
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
General Cannabis News
PremiumCompany Announcements
General Cannabis Expands and Restructures Leadership
Options Prices
Currently, No data available
---
Ownership Overview
1.22%
Insiders
―
Mutual Funds
<0.01% Other Institutional Investors
98.77% Public Companies and
Individual Investors
7A7 FAQ
What was General Cannabis’s price range in the past 12 months?
General Cannabis lowest stock price was €0.10 and its highest was €0.10 in the past 12 months.
What is General Cannabis’s market cap?
General Cannabis’s market cap is €2.53M.
When is General Cannabis’s upcoming earnings report date?
General Cannabis’s upcoming earnings report date is Aug 07, 2025 which is in 58 days.
How were General Cannabis’s earnings last quarter?
General Cannabis released its earnings results on Aug 08, 2024. The company reported -€0.009 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.009.
Is General Cannabis overvalued?
According to Wall Street analysts General Cannabis’s price is currently Overvalued.
Does General Cannabis pay dividends?
General Cannabis does not currently pay dividends.
What is General Cannabis’s EPS estimate?
General Cannabis’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does General Cannabis have?
General Cannabis has 108,746,520 shares outstanding.
What happened to General Cannabis’s price movement after its last earnings report?
General Cannabis reported an EPS of -€0.009 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of General Cannabis?
Currently, no hedge funds are holding shares in DE:7A7
Company Description
General Cannabis
Trees Corporation provides products and services to the regulated cannabis industry and non-cannabis customers in the United States. The company operates through Retail and Cultivation segments. It operates a licensed 17,000 square foot light deprivation greenhouse cultivation facility; and a retail dispensary store in Englewood, Colorado, as well as two retail stores in Portland, Oregon. The company was formerly known as General Cannabis Corp. and changed its name to Trees Corporation in June 2022. Trees Corporation was incorporated in 2013 and is headquartered in Denver, Colorado.
Technical Analysis
Durect
―
Aytu BioScience
―
Organogenesis Holdings
―
Kala Pharmaceuticals
―
China SXT Pharmaceuticals
―